Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Atomo Diagnostics Ltd. ( (AU:AT1) ).
Atomo Diagnostics has withdrawn a previously lodged Appendix 3B relating to a proposed issue of securities under a securities purchase plan. The company advised the ASX that the filing is not required, effectively cancelling the earlier announcement and indicating that no new securities will be issued under that specific proposal at this time.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. is an Australian-listed medical diagnostics company focused on rapid blood-based testing devices. The company develops and commercialises point-of-care diagnostic solutions, targeting markets where quick, user-friendly testing is required, and its shares trade on the ASX under the code AT1.
Average Trading Volume: 2,349,202
Technical Sentiment Signal: Hold
Current Market Cap: A$25.23M
See more insights into AT1 stock on TipRanks’ Stock Analysis page.